{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:02:44Z","timestamp":1778846564569,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jcv.2025.105760","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T17:38:35Z","timestamp":1735839515000},"page":"105760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Highly-multiplex detection of plasma cell-free human papillomavirus-16 DNA in oropharyngeal carcinoma"],"prefix":"10.1016","volume":"176","author":[{"given":"Payton","family":"Clark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalya","family":"Karasik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shauna R.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil M.","family":"Woody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie A.","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Bottalico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon L.","family":"Prendes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Lamarre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Scharpf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara A.","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy A.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomo A.","family":"Koyfman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2025.105760_bib0001","article-title":"Trends in human papillomavirus\u2013associated cancers \u2014 United States, 1999\u20132015","volume":"67","author":"Dyne","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.jcv.2025.105760_bib0002","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jamaoto.2021.3567","article-title":"Oropharyngeal cancer incidence and mortality trends in all 50 states in the US, 2001-2017","volume":"148","author":"Damgacioglu","year":"2022","journal-title":"JAMA Otolaryngol. Neck Surg."},{"key":"10.1016\/j.jcv.2025.105760_bib0003","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.2907","article-title":"Projected association of human papillomavirus vaccination with oropharynx cancer incidence in the US, 2020-2045","volume":"7","author":"Zhang","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jcv.2025.105760_bib0004","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.jcv.2025.105760_bib0005","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1158\/1078-0432.CCR-19-2384","article-title":"HPV sequencing facilitates ultrasensitive detection of HPV circulating tumor DNA","volume":"27","author":"Leung","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jcv.2025.105760_bib0006","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1200\/JCO.19.02444","article-title":"Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer","volume":"38","author":"Chera","year":"2020","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.jcv.2025.105760_bib0007","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/j.ijrobp.2011.05.061","article-title":"Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients","volume":"82","author":"Cao","year":"2012","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.jcv.2025.105760_bib0008","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijrobp.2022.02.012","article-title":"Detectable postoperative circulating tumor human papillomavirus DNA and association with recurrence in patients with HPV-associated oropharyngeal squamous cell carcinoma","volume":"113","author":"Routman","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jcv.2025.105760_bib0009","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1158\/1078-0432.CCR-23-1478","article-title":"Negative predictive value of circulating tumor tissue modified viral (TTMV)-HPV DNA for HPV-driven oropharyngeal cancer surveillance","volume":"29","author":"Hanna","year":"2023","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.jcv.2025.105760_bib0010","series-title":"Early Disease Recurrence Following Post-Operative HPV ctDNA Directed Active Surveillance in Oropharyngeal Carcinoma \u2013 Outcomes of a Prospective Pilot Study","author":"Chen","year":"2024"},{"key":"10.1016\/j.jcv.2025.105760_bib0011","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.jcv.2025.105760_bib0012","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ijrobp.2024.08.014","article-title":"Interim futility results of NRG-HN005, A randomized, phase II\/III non-inferiority trial for non-smoking p16+ oropharyngeal cancer patients","volume":"120","author":"Yom","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jcv.2025.105760_bib0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41591-022-02115-4","article-title":"Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer","volume":"29","author":"Kotani","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.jcv.2025.105760_bib0014","doi-asserted-by":"crossref","first-page":"CT009","DOI":"10.1158\/1538-7445.AM2024-CT009","article-title":"Abstract CT009: iMvoke010: a phase III, double-blind randomized trial of atezolizumab (atezo) after definitive local therapy vs placebo in patients (pts) with high-risk locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN)","volume":"84","author":"Wong","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcv.2025.105760_bib0015","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1470-2045(24)00100-1","article-title":"Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial","volume":"25","author":"Machiels","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcv.2025.105760_bib0016","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1470-2045(20)30737-3","article-title":"Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial","volume":"22","author":"Lee","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcv.2025.105760_bib0017","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/jamaoto.2014.1338","article-title":"Saliva and plasma quantitative polymerase chain reaction\u2013based detection and surveillance of human papillomavirus\u2013related head and neck cancer","volume":"140","author":"Ahn","year":"2014","journal-title":"JAMA Otolaryngol.\u2013 Head Neck Surg."},{"key":"10.1016\/j.jcv.2025.105760_bib0018","unstructured":"Centers for medicare and medicaid services, 2019 medicare clinical laboratory fee schedule, (2019). https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/ClinicalLabFeeSched\/Clinical-Laboratory-Fee-Schedule-Files-Items\/19CLABQ1.html?DLPage=1&DLEntries=10&DLSort=2&DLSortDir=descending (accessed January 20, 2019)."},{"key":"10.1016\/j.jcv.2025.105760_bib0019","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1701717","article-title":"Analysis of plasma epstein-barr virus DNA to screen for nasopharyngeal cancer","volume":"377","author":"Chan","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2025.105760_bib0020","first-page":"1188","article-title":"Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma","volume":"59","author":"Lo","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcv.2025.105760_bib0021","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jama.2022.13997","article-title":"Effect of radiotherapy alone vs radiotherapy with concurrent chemoradiotherapy on survival without disease relapse in patients with low-risk nasopharyngeal carcinoma: a randomized clinical trial","volume":"328","author":"Tang","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2025.105760_bib0022","first-page":"S23","article-title":"Evaluating assay precision","volume":"29","author":"Chesher","year":"2008","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.jcv.2025.105760_bib0023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40463-016-0179-6","article-title":"HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours","volume":"46","author":"Wasserman","year":"2017","journal-title":"J. Otolaryngol. - Head Neck Surg."},{"key":"10.1016\/j.jcv.2025.105760_bib0024","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/diagnostics13040725","article-title":"Analytical validation of NavDx, a cfDNA-based fragmentomic profiling assay for HPV-driven cancers","volume":"13","author":"Gunning","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.jcv.2025.105760_bib0025","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.6002","article-title":"A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT)","volume":"35","author":"Chan","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jcv.2025.105760_bib0026","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1158\/1078-0432.CCR-12-3702","article-title":"An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma","volume":"19","author":"Le","year":"2013","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.jcv.2025.105760_bib0027","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1200\/JCO.23.01308","article-title":"Hypoxia-directed treatment of human papillomavirus\u2013related oropharyngeal carcinoma","volume":"42","author":"Lee","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jcv.2025.105760_bib0028","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.ijrobp.2024.01.031","article-title":"FDG-PET-based selective de-escalation of radiotherapy for HPV-related oropharynx cancer: results from a phase II trial","volume":"118","author":"Regan","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jcv.2025.105760_bib0029","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1016\/j.ijrobp.2022.07.1385","article-title":"Circulating tumor HPV-DNA kinetics in p16+ oropharyngeal cancer patients undergoing adaptive radiation de-escalation based on mid-treatment nodal response","volume":"114","author":"Kim","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jcv.2025.105760_bib0030","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.6066","article-title":"Can TTMV clearance predict recurrence in HPV HNSCC?","volume":"42","author":"Misiukiewicz","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jcv.2025.105760_bib0031","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1038\/s41467-019-11853-y","article-title":"Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma","volume":"10","author":"Lv","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653225000010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653225000010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T12:42:53Z","timestamp":1741005773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653225000010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":31,"alternative-id":["S1386653225000010"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2025.105760","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly-multiplex detection of plasma cell-free human papillomavirus-16 DNA in oropharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2025.105760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105760"}}